We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Buy buy bispecific antibodies.
- Authors
Holmes, David
- Abstract
The article focuses on bispecific antibodies's development, which captured the interest of several companies such as Merck & Co. and Zymeworks Inc. It says that the effectiveness of monospecific monoclonal antibodies (mAbs) has resulted to the advancement of having several strategies in developing next-generation antibodies. Acccording to Nicholas Fischer, NovImmune's head of research, taking an inventive creative format is a major barrier in bispecific manufacturing.
- Subjects
BISPECIFIC antibodies; MONOCLONAL antibody probes; PHARMACEUTICAL chemicals manufacturing; MERCK &; Co. Inc.; ZYMEWORKS Inc.; FISCHER, Nicholas; NOVIMMUNE SA
- Publication
Nature Reviews Drug Discovery, 2011, Vol 10, Issue 11, p798
- ISSN
1474-1776
- Publication type
Article
- DOI
10.1038/nrd3581